Panbela Therapeutics

(OTC) PBLA

Current Price$0.00

Market CapN/A

Since IPO (2015)-100%

5 YearN/A

1 Year-100%

1 Month-100%

Panbela Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$27.91M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3366.93 (High)

Dividend

$0.00

Beta (Volatility)

3366.93 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $2.50

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

3366.93 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $2.50

Estimated Earnings Date

Aug 12, 2026

PBLA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Panbela Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jennifer K. Simpson, PhD

Website

www.panbela.com

Headquarters

Waconia, MN 55387, US

PBLA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

99%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

4.85M

Volume

Avg. Volume

1.20K

Financials (TTM)

Gross Profit

-$25.65M

Operating Income

-$51.29M

EBITDA

-$51.29M

Operating Cash Flow

-$25.25M

Capital Expenditure

$0.00

Free Cash Flow

-$25.25M

Cash & ST Invst.

$2.58M

Total Debt

$5.19M

Panbela Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$7.17M

+8.7%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$7.17M

+8.4%

EBITDA

-$6.73M

+14.2%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Total Cash

$142.00K

-84.3%

Total Debt

$6.39M

+23.1%

Accounts Receivable

$332.00K

+114.2%

Inventory

$0.00

N/A

Long Term Debt

$3.19M

-23.8%

Short Term Debt

$3.20M

+220.0%

Return on Assets

-2.14%

N/A

Return on Invested Capital

99.41%

N/A

Free Cash Flow

-$2.12M

+68.2%

Operating Cash Flow

-$2.12M

+68.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MOBOMobile Lads Corp.

MOBOMobile Lads Corp.$0.00+0.00%

BRAXFBraxia Scientific Corp.

BRAXFBraxia Scientific Corp.$0.00+0.00%

HTDSHard to Treat Diseases Inc.

HTDSHard to Treat Diseases Inc.$0.00+0.00%

IRBSIR Biosciences Holdings Inc.

IRBSIR Biosciences Holdings Inc.$0.00+0.00%

NVOSNovo Integrated Sciences, Inc.

NVOSNovo Integrated Sciences, Inc.$0.00-61.11%

BBBTBlack Bird Biotech, Inc.

BBBTBlack Bird Biotech, Inc.$0.00+0.00%

ADVTAdvantis Corp.

ADVTAdvantis Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.52+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.75+0.01%

CUPRCuprina (Cayman)

CUPRCuprina (Cayman)$10.33+1.60%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.27-0.09%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$177.08+0.10%

NOKNokia

NOKNokia$14.66-0.01%

NVDANvidia

NVDANvidia$212.20+0.03%

Questions About PBLA

What is the current price of Panbela Therapeutics?

Panbela Therapeutics is trading at $0.00 per share.

What is the 52-week range for Panbela Therapeutics?

Over the past 52 weeks, Panbela Therapeutics has traded between $0.00 and $2.50.

How much debt does Panbela Therapeutics have?

As of the most recent reporting period, Panbela Therapeutics reported total debt of $6.39M.

How much cash does Panbela Therapeutics have on hand?

Panbela Therapeutics reported $142.00K in cash and cash equivalents in its most recent financial results.

What is Panbela Therapeutics’s dividend yield?

Panbela Therapeutics does not currently have a dividend yield.

Panbela Therapeutics

Panbela Therapeutics Financials at a Glance

PBLA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Panbela Therapeutics

PBLA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Panbela Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PBLA

What is the current price of Panbela Therapeutics?

What is the 52-week range for Panbela Therapeutics?

How much debt does Panbela Therapeutics have?

How much cash does Panbela Therapeutics have on hand?

What is Panbela Therapeutics’s dividend yield?

Premium Investing Services